Stock Research: Accuray

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

What's New

Recent improvements to enhance your investment research experience

360° View free for everyone

Our most comprehensive analysis—the 360° View—is now free for everyone. To maintain our research quality, other ranks are now part of our new subscription plans.

3 new subscription models

Plans for every investor - from stock ideas to in-depth analysis.

Similar Stocks

Four stock alternatives to the stock you're searching.

Accuray

NasdaqGS:ARAY US0043971052
29
  • Value
    64
  • Growth
    3
  • Safety
    Safety
    58
  • Combined
    23
  • Sentiment
    51
  • 360° View
    360° View
    29
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Accuray Incorporated is a radiation therapy company. The company operates in the healthcare industry, specializing in radiation treatment solutions, including CyberKnife and TomoTherapy platforms. The company operates globally, providing its solutions and services worldwide. In the last fiscal year, the company had a market cap of $137 million, profits of $143 million, and revenue of $447 million, with 987 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 29 (better than 29% compared with alternatives), overall professional sentiment and financial characteristics for the stock Accuray are below the industry average. The 360° View is based on consolidating four consolidated indicators, with half of the indicators below and half above average for Accuray. The consolidated Value Rank has an attractive rank of 58, which means that the share price of Accuray is on the lower side compared with typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 58% of alternative stocks in the same industry. The company is also safely financed with a Safety rank of 64. In addition, professional market sentiment is above average compared with other stock investment alternatives with a Sentiment Rank of 51. But the consolidated Growth Rank has a low rank of 3, which means that the company is below average in terms of growth and momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. 97 of its competitors have better growth. ...read more

more
Index
NASDAQ
D.J. US Medical Equipment
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 21-Aug-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
58 58 48 61
Growth
3 41 89 29
Safety
Safety
64 64 50 72
Sentiment
51 65 74 32
360° View
360° View
29 82 98 41
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
100 100 97 84
Opinions Change
67 86 50 50
Pro Holdings
n/a 1 45 8
Market Pulse
3 44 48 19
Sentiment
51 65 74 32
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
58 58 48 61
Growth
3 41 89 29
Safety Safety
64 64 50 72
Combined
23 67 89 50
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
1 31 1 50
Price vs. Earnings (P/E)
91 87 89 95
Price vs. Book (P/B)
69 49 34 28
Dividend Yield
1 1 1 1
Value
58 58 48 61
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
10 23 20 11
Profit Growth
22 81 98 82
Capital Growth
33 62 67 15
Stock Returns
23 33 89 57
Growth
3 41 89 29
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
20 7 8 7
Refinancing
85 80 73 85
Liquidity
44 61 67 67
Safety Safety
64 64 50 72

Similar Stocks

Discover high‑ranked alternatives to Accuray and broaden your portfolio horizons.

Micron

NasdaqGS:MU
Country: USA
Industry: Semiconductors
Size: X-Large
Full Stock Analysis

Meta

NasdaqGS:FB
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Alphabet

NasdaqGS:GOOG.L
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Lithia Motors

NYSE:LAD
Country: USA
Industry: Automotive Retail
Size: X-Large
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.